XML 47 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock (Tables)
 12 Months Ended
Feb. 28, 2023
Equity [Abstract]  
Schedule of outstanding share purchase warrants
         
   Number of
Warrants		   Weighted Average
Exercise Price		 
Balance, February 28, 2020   —   $— 
Issued in Connection with October 2020 Offering   488,500   $2.10 
Issued in Connection with January 2021 Offering   1,604,334   $3.00 
Exercised   (25,000)  $2.00 
Balance, February 28, 2021   2,067,834   $2.80 
Exercised   (221,666)  $2.44 
Balance, February 28, 2022   1,846,168   $2.84 
Issued in Connection with August 2022 Offering   3,478,261   $1.75 
Expired   (50,000)  $3.00 
Issued in Connection with August 2022 Offering   168,000   $1.75 
Issued in Connection with September 2022 Offering   350,000   $5.00 
Issued in Connection with November 2022 Offering   28,312   $8.22 
Issued in Connection with November 2022 Offering   10,000   $6.70 
Exercised   (100,000)  $2.00 
Exercised   (90,000)  $3.00 
Issued in Connection with October 2022 Offering   125,000   $5.00 
Cashless Exercised   (3,478,261)  $1.75 
Balance, February 28, 2023   2,287,480   $3.32 
Schedule of share purchase warrants outstanding and exercisable
              
    Number of Warrants   Remaining Contractual     
Exercise Price   Outstanding   Life (Years)   Expiry Date 
$2.00    188,500    0.14    19-Apr-2023 
$3.00    1,417,668    0.37    13-Jul-2023 
$1.75    168,000    4.44    9-Aug-2027 
$5.00    350,000    1.56    19-Sep-2024 
$8.22    28,312    2.68    4-Nov-2025 
$6.70    10,000    2.73    21-Nov-2025 
$5.00    125,000    1.89    1-Oct-2024 
$3.32    2,287,480           
Schedule of valuation assumptions
         
   February 28,
2023		   February 28,
2022		 
Expected Risk-Free Interest Rate   1.06%   1.06%
Expected Volatility   15.27%   15.27%
Expected Life in Years   5.0    5.0 
Expected Dividend Yield   —    — 
Weighted-Average Grant Date Fair Value  $6.46   $6.46 
Schedule of stock option activity
         
   Number of Stock Options   Exercise Price 
Balance, February 28, 2022   3,636,000   $8.00 
Vested   (714,200)   — 
Cancelled/Forfeited   (779,200)   8.00 
Expired   —    — 
Balance, February 28, 2023   2,142,600   $3.84 
Schedule of number of issued shares and cash received upon exercise of stock options
                 
    February 28,
2023		     February 28,
2022		  
Number of Options Exercised on Forfeiture Basis     —       —  
Number of Options Exercised on Cash Basis     —       —  
Total Number of Options Exercised     —       —  
                 
Number of Shares Issued on Cash Exercise     —       —  
Number of Shares Issued on Forfeiture Basis     —       —  
Total Number of Shares Issued Upon Exercise of Options     —       —  
                 
Cash Received from Exercise of Stock Options   $ —     $ —  
Total Intrinsic Value of Options Exercised   $ —     $ —  
Schedule of unvested restricted stock
                 
    Number of Unvested     Weighted Average  
    Stock Options     Grant Date Fair Value  
Balance, February 28, 2021     —       —  
Granted     4,545,000     $ 6.46  
Vested     (909,000 )   $ 6.46  
Balance, February 28, 2022     3,636,000     $ 6.46  
Granted     —       —  
Vested     (714,200 )      —  
Cancelled / Forfeited     (779,200 )     6.46  
Balance, February 28, 2023     2,142,600     $ 6.46  
Schedule of stock options
                         
    Options Outstanding    Options Exercisable 

Range of Exercise

Prices

   

Outstanding at

February 28, 2023

    Exercise Price    

Weighted Average Remaining

Contractual Term

(Years)

    Exercisable at February 28, 2023    Exercise Price    

Weighted Average Remaining

Contractual Term

(Years)

 
$7.00 to $9.00   2,142,600   $3.84    3.83    1,623,200   $3.84    3.83 
                               
    2,142,600   $3.84    3.83    1,623,200   $3.84    3.83